Against the Storm: High-Dose IVIG as an Immunoregulatory Treatment Strategy for Severe COVID-19
While there may be no “magic bullet” to treat cytokine storm, one widely used immunomodulatory agent in particular — polyclonal intravenous immune globulin (IVIG) purified from healthy donor plasma — is distinguished by the simple fact that it is anything but a narrowly targeted treatment.
Myths & Facts: Childhood Vaccines
Despite proof of lifesaving benefits of vaccines, parental hesitancy to immunizing their children is often fueled by the plethora of myths surrounding vaccine safety.
New Vaccines in Development
Beyond COVID-19 vaccines, research is showing potential for new vaccines to treat several other diseases.
COVID-19 Vaccines: Where Are We Now?
With three vaccines in circulation and three more on the horizon, is the end of the COVID-19 pandemic in sight?
Emerging Novel Viruses
With trillions of viruses living in the human and other species’ microbiomes, the possibility of novel viruses such as COVID-19 emerging is high, but the threat they may pose is unknown.
In Case of a Shortage: Strategies to Conserve the Immune Globulin Supply
What can be done in the event of a severe shortage of IG products, whose production is entirely reliant on a continuous supply of IgG-rich plasma donated at more than 800 dedicated U.S. collection facilities?
Tackling Sepsis in Hospitals
By raising awareness and developing tools to detect sepsis earlier, healthcare organizations save lives from this often-deadly infection.
Myths & Facts: Antibiotics
To staunch the growing threat of antibiotic resistance, the medical profession is pivotal in properly prescribing antibiotics and educating patients about their appropriate use.
Importing Drugs: Is It Safe and Responsible?
As Americans continue to grapple with the skyrocketing costs of prescription drugs, many are turning to other countries to access medications they need at prices they can afford.
Long-Term Effects of COVID-19
Long-haul COVID, now termed PASC, is a very real effect of the SARs-CoV-2 virus, but few physicians are familiar with the symptoms and where to send patients for treatment.
